Results 91 to 100 of about 2,147 (178)

Correction to: Rilonacept (Interleukin‑1 Inhibition) for the Treatment of Pericarditis [PDF]

Current Cardiology Reports, 2022
Wang, Tom Kai Ming, Klein, Allan L.
openaire   +1 more source

Rilonacept Reduces Pericarditis Recurrence Risk, Hospitalizations, and ED visits: Outcomes from the RESONANCE Patient Registry [PDF]

RILONACEPT REDUCES PERICARDITIS RECURRENCE RISK, HOSPITALIZATIONS, AND ED VISITS: OUTCOMES FROM THE RESONANCE PATIENT REGISTRYPaul C. Cremer, MD1, Michael S. Garshick, MD2,3, Sushil A.
Ryan, John J., Hagerty, Tracey, Al-Kazaz, Mohamed, Paolini, John F., Weber, Brittany, Garshick, Michael S., Raisinghani, Ajit, Klein, Allan L., Parameswaran, Vidhya, Corey, Taylor, Salik, Jonathan R., Cremer, Paul C., Luis, Sushil A., RESONANCE Study Group   +13 more
core  

Canakinumab i rilonacept per al tractament de les síndromes periòdiques associades a la criopirina

Síndromes periòdiques associades a criopirina; Canakinumab; Assaigs clínics; Rilonacept;Cryopyrin-Associates Periodic Syndrome; CAP; Clinical Trial; Síndromes periódicos asociados a criopirina; Ensayos ClínicosLes síndromes periòdiques associades a ...
Comitè d’Avaluació de Medicaments d’Ús Hospitalari (CAMUH)
core  

Comparative Efficacy and Safety of Colchicine and Interleukin-1 Antagonists in Recurrent Pericarditis: A Network Meta-Analysis

INTRODUCTION: Despite advancement of therapeutic approaches to recurrent pericarditis, it poses notable challenges to its\u27 management. As per the current guidelines, colchicine is the first line therapy, although, non-conventional treatments like ...
Agrawal, Siddharth P., Maheta, Darshilkumar, Panchal, Akx, Desai, Dev, Shah, Abhijay B., Shah, Hetvi, Aronow, Wilbert S.   +6 more
core   +1 more source

Recurrent Pericarditis in a Rugby Player: Imaging-Guided Therapy. [PDF]

JACC Case Rep
Abuawad A, Badwan O, Ehsan M, Thabaja C, Massad F, Mahmoud M, Besir B, Ahmed A, Ikram J, Wang TKM, Klein A.   +10 more
europepmc   +1 more source

Retraction Note: Real-world data and Mendelian randomization analysis in assessing adverse reactions of rilonacept. [PDF]

Int J Clin Pharm
Liu L, Chi Z, Zhang Z.
europepmc   +1 more source

Recurrent Pericarditis Evolving to Constrictive Pericarditis and Pericardiectomy Over 18 Years. [PDF]

JACC Case Rep
Ehsan M, Ikram J, Villalonga M, El Roumi J, Ehsan S, Syed AB, Alqahtani M, Tan CD, Klein AL.   +8 more
europepmc   +1 more source

Deficiency of interleukin-1 receptor antagonist: A systematic review

The Turkish Journal of Gastroenterology
Objectives: The study aimed to conduct a systematic literature review of the epidemiology, pathophysiology, clinical presentation, diagnosis, and treatment of patients with deficiency of the interleukin-1 receptor antagonist (DIRA) and determine the ...
Wérgila Ruana Gonçalves Barros, Jucier Gonçalves Júnior   +1 more
doaj  

Comment on "Risk of Pericarditis Recurrence Associated With Rilonacept and NSAID/Colchicine Therapy After Initial Pericarditis Presentation: A Retrospective Real-World Comparative Risk Analysis With TriNetX". [PDF]

Am J Ther
Parameswaran V, Wang S, Clair J.
europepmc   +1 more source

Refractory recurrent pericarditis associated with MEFV E148Q variant: selective response to IL-1 receptor antagonism. [PDF]

EULAR Rheumatol Open
Haider SW.
europepmc   +1 more source